Skip to main content
. 2021 May 7;2021:5510552. doi: 10.1155/2021/5510552

Table 6.

Comparisons of demographic features, comorbidities, biochemical profiles, and genomic profiles within three-combined traditional Chinese medicine body constitutions (TCMBC) and balanced constitution (no inclined to any of three types) obesity enrollees.

Parameters TCMBC
Three-combined (n = 22) Balanced (n = 11) P
Demographic features
 Gender <0.001
  Female 20 (90.9%) 4 (36.4%)
  Male 2 (9.1%) 7 (63.6%)
 Age (years), mean (SD) 38.4 (10.9) 35.0 (10.2) 0.40
 BMI, mean (SD) 30.5 (3.1) 31.3 (3.3) 0.50
 Waist-hip ratio (WHR), mean (SD) 0.9 (0.1) 0.9 (0.0) 0.27
 Waist-height ratio (WheR), mean (SD) 0.6 (0.1) 0.6 (0.0) 0.47
Appetite 0.53
 Poor 2 (9.1%) 0 (0.0%)
 Fair 19 (86.4%) 10 (90.9%)
 Good 1 (4.5%) 1 (9.1%)
Food preference
 Icy food 7 (31.8%) 1 (9.1%) 0.15
 Deep-fried food 6 (27.3%) 0 (0.0%) 0.056
Smoking 1 (4.5%) 0 (0.0%) 0.47
Alcohol consumption 7 (31.8%) 7 (63.6%) 0.081
Exercise ≥30 mins/week 17 (77.3%) 8 (72.7%) 0.77
Comorbidities
 Hyperlipidemia 1 (4.5%) 0 (0.0%) 0.47
 Hypertension 4 (18.2%) 2 (18.2%) 1.00
 Diabetes mellitus 0 (0.0%) 2 (18.2%) 0.039
 Stroke 0 0 1.00
 Myocardial infarction 0 0 1.00
 Allergic rhinitis 6 (27.3%) 1 (9.1%) 0.23
 Polycystic ovarian syndrome 0 0 1.00
Biochemical profiles
 Fasting sugar 92.4 (13.1) 101.7 (33.2) 0.25
 HbA1c 6.1(0.5) 6.1 (0.9) 0.74
 eAG 127.0 (13.0) 129.4 (25.7) 0.73
 HDL 47.6 (10.3) 55.1 (24.6) 0.23
 VLDL 31.5 (21.9) 31.6 (19.2) 0.99
 LDL 126.9 (34.1) 129.9 (27.7) 0.80
 Total cholesterol 199.2 (42.8) 201.6 (29.3) 0.87
 Total cholesterol/HDL 4.3 (1.2) 4.4 (1.0) 0.92
 LDL/HDL 2.8 (0.9) 2.8 (0.7) 0.89
 Triglyceride 163.2 (132.2) 165.1 (110.7) 0.97
 Leptin 27.7 (23.9) 11.3 (8.8) 0.036
 Insulin 12.1 (5.3) 11.1 (4.7) 0.59
 HOMA-IR 2.9 (1.7) 3.9 (4.0) 0.29
 Adiponectin 7.2 (5.2) 6.5 (3.2) 0.70

HbA1c, glycated hemoglobin; eAG, estimated average glucose; HDL, high-density lipoprotein; VLDL, very low-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance.